Bill Few Associates’s Gilead Sciences GILD Stock Holding History

Bill Few Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Buy	3,247 +153	+5%	+$20.2K	0.09%	147
2026 Q1	$431K	Buy	3,094 +37	+1%	+$5.18K	0.1%	134
2025 Q4	$375K	Sell	3,057 -336	-10%	-$40.8K	0.09%	139
2025 Q3	$377K	Buy	3,393 +439	+15%	+$49.9K	0.1%	138
2025 Q2	$328K	Sell	2,954 -1,000	-25%	-$106K	0.09%	143
2025 Q1	$443K	Hold	3,954	–	–	0.16%	105
2024 Q4	$365K	Hold	3,954	–	–	0.13%	121
2024 Q3	$332K	Buy	3,954 +234	+6%	+$17.9K	0.12%	128
2024 Q2	$255K	Buy	3,720 +500	+16%	+$33.4K	0.1%	145
2024 Q1	$236K	Buy	3,220 +315	+11%	+$24.2K	0.1%	146
2023 Q4	$235K	Sell	2,905 -500	-15%	-$38.9K	0.11%	135
2023 Q3	$255K	Buy	+3,405	New	+$262K	0.13%	114

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Bill Few Associates's GILD Position: Q2 2026 in Review

Bill Few Associates increased its Gilead Sciences (GILD) stake by 4.9% in Q2 2026, buying an estimated $20.2K and bringing the position to 3,247 shares worth $410K. The position accounts for 0.09% of the portfolio, ranked #147.

Bill Few Associates first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $443K in Q1 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Bill Few Associates held 3,247 shares of Gilead Sciences worth $410K as of Q2 2026.
Bill Few Associates bought 153 Gilead Sciences shares in Q2 2026, an estimated $20.2K.
Gilead Sciences made up 0.09% of Bill Few Associates's portfolio in Q2 2026, its #147 holding.
Bill Few Associates first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
Bill Few Associates's Gilead Sciences position peaked at $443K in Q1 2025.
361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.